volume 7, number 1 winter newsletter march, 2008wizard.musc.edu/nlw2008.pdf1 volume 7, number 1...
TRANSCRIPT
1
Volume 7, Number 1 Winter Newsletter March, 2008
Zablocki, Gibbs and Woster Elected to ACSMEDI Executive Committee
In elections that were held electronically between October 23 and November 21 of 2007, Jeff Zablocki (CV Therapeutics) was elected Vice Chair of the Division, and begins a 5 year rotation in Division leadership. Richard Gibbs (Purdue) was elected Academic Counselor, and will serve in this capacity during 2008-10. Richard Glennon (Virginia Commonwealth Univ.) will serve as Alternate Councilor for a similar term. Patrick M. Woster was also re-elected as Secretary and Public Relations Chair for 2008-2010. The 2008 Executive Committee members are:
2008 Chair: Donald J. Abraham 2008 Program Chair: James R. McCarthy
2008 Vice-Chair: Jeff Zablocki Industrial Councilor 2006-08: Peter R. Bernstein
Industrial Councilor 2007-09: Ravi Nargund Academic Councilor 2008-10: Richard A. Gibbs Academic Councilor 2006-08: Gunda I. Georg Secretary/PR Chair 2008-10: Patrick M. Woster
Membership Chair: Yanping Xu Treasurer 2006-08: Danny Lattin 2008 Past Chair: David Rotella
Contact information for all Division Officers appears at the end of this Newsletter.
Redesigned Division of Medicinal Chemistry
Hall of Fame Now On Line
The Division of Medicinal Chemistry Hall of Fame has been completely redesigned, and can be accessed through the Division WWW page. The HOF was created to honor scientists who have made outstanding contributions to the field, and preserves the history of our discipline.
http://www.acsmedchem.org/hofmain.html
Preliminary Program for the New Orleans
ACS Meeting (April 6-10, 2008)
SUN AM HIV Integrase Inhibitors SUN AM General Oral Session I SUN PM First Time Disclosures SUN EVE Poster Session I and Social Hour MON AM Burger Award Symposium MON PM Fluorine in Drug Design MON PM Non-Monoamine Antidepressants TUES AM ABC Transporters/P-Glycoprotein TUES AM Latest and Greatest in Chemokines TUES NOON Lunch and Learn Case Study TUES PM Lysine-Specific Demethylase 1 TUES PM General Oral Session II WED AM Natural Products/Signal Transduction WED AM Hits to Leads WED PM Mutasynthesis WED PM Solubility-Driven SAR WED EVE Poster Session II THURS AM Fatty Acid Synthase Inhibitors THURS AM General Oral Session III THURS PM General Oral Session IV
Preliminary Program for the Philadelphia ACS Meeting (August 17-21, 2008)
OASYS open now and closes March 17, 2008
SUN AM Predoctoral Fellowship Sympsoim SUN AM General Oral Session I SUN PM Allosteric Kinase Inhibitors SUN EVE Poster Session I and Social Hour MON AM Robertson/Scarborough Symposium MON PM Progesterone Receptor MON PM Adjunctive Therapy for Schizophrenia TUES AM Role of Purogenic Signaling System TUES AM Histamine H3 Receptor Antagonists TUES NOON Lunch and Learn Case Study TUES PM Ligand-Gated Ion Channels in CNS TUES PM General Oral Session II WED AM Structure-Based Drug Design
(Brazilian Chemical Society) WED AM Lipid Metabolism/Metabolic Synd. WED PM SBDD and GCPR Targets WED PM Blood-Brain Barrier in Drug Discovery WED EVE Poster Session II THURS AM Array-Driven Lead Optimization THURS AM General Oral Session III THURS PM General Oral Session IV
2
Division Travel Grants
The Division of Medicinal Chemistry makes 14 grants of $600 - $1000 available annually to aid young chemists in presenting papers at the ACS National Meetings. Applicants must be ACS members (student or affiliate) and not have previously received a travel award. Each University department can have only one awardee. Application deadlines are the same as the abstract deadline for each meeting. In order of priority, the following individuals will be considered for awards: Graduate Student, Postdoctoral Fellow, individual with less than five years post-Ph.D. experience. The scientific merit of the paper to be presented will also be con-sidered. Send applications to:
James R. McCarthy, Ph.D. Drop Code 1920
1 Lilly Corporate Center Indianapolis, IN 46285-0002
(317) 433-1345 [email protected]
Awardees will be notified in sufficient time so that they can pre-register for the meeting. Awards are made at the Division business meeting, which is held at each national meeting immediately before the Sunday night poster session and mixer. Address info and a complete application for the award appears on page 3.
Invitation to Authors: Journal of Medicinal Chemistry Perspective Series
The Perspective series of the Journal of Medicinal Chemistry is designed to provide an enlightened appraisal of a field of research in which experts review the state-of-the-art for a given area or therapeutic target. Authors have editorial freedom to express their views on the strategic directions of the field of research. The Perspective series provides a forum with high visibility within the pharmaceutical industry and academia. We would like to identify a wide range of potential topics and authors to ensure that a Perspective article is published in every issue of the Journal. We would like the series to be useful to a broad range of scientists interested in the design, discovery and development of novel medicines. We invite you
to submit an idea for a Perspective, along with a brief outline of what you will cover in the manuscript. We also welcome your input regarding potential topics of interest and authors for Perspective manuscripts. Please direct correspondence or calls regarding the series to:
William J. Greenlee Schering-Plough Research Institute
2015 Galloping Hill Road Kenilworth, NJ 07033 Phone (908)-740-2220 FAX (908)-740-7164
CALL FOR PAPERS 236th NATIONAL ACS MEETING
Philadelphia, PA, August 17-21, 2008 Abstracts Due by March 17, 2008.
You are invited to submit an abstract for a research presentation at the 236th National Meeting of the American Chemical Society, to be held August 17-21, 2008 in Philadelphia, PA. All abstracts should be submitted online using the OASYS system, which is now available for the Philadelphia meeting. The deadline for submission of abstracts will be March 17, 2008. This date will also be the deadline for submission of travel grant applications, as outlined above and on page 3 of this Newsletter. Please watch the Division Homepage, located at:
http://www.acsmedchem.org/
for additional information. The MEDI scientific program and abstracts will be available for download 3-4 weeks prior to the meeting, and their availability will be announced by electronic mail. For more information on programming or abstract submission, contact the Program Chair, James McCarthy at
Abstracts for the New Orleans ACS Meeting Available for Download
Follow the link below to download the MEDI abstracts for the New Orleans ACS meeting:
www.acsmedchem.org/mediabstracts2008.pdf
3
ACS Division of Medicinal Chemistry Student Travel Grants
APPLICANTS MUST SUBMIT AN ABSTRACT SEPARATELY VIA OASYS SYSTEM The deadline for Travel Grant applications is the same as the abstract deadline for that meeting
* Name of Applicant for Travel Grant ______________________________________________ * Degree: ___________________________ Year Obtained ______________________________ * Present Institution: _______________________________________________________________ * Department: _____________________________________________________________________ *E-mail Address: _____________________________________________________________________ * Work to be reported was (check one or more): a. Ph.D. Thesis __________ b. M.S. Thesis __________ c. Postdoctoral Fellowship __________ *Supported by (indicate source of support for this work): a. Grant ____________________ b. Department ____________________ c. Other ____________________ Send the completed application form and a copy of the OASYS abstract to:
James R. McCarthy, Ph.D. Drop Code 1920
Lilly Corporate Center Indianapolis, IN 46285-0002
(317) 433-1345 [email protected]
Learn more at: http://www.acdlabs.com/1dnmrassistant/
Meet us at ACS Spring Booth #1338
The Mouse is MightierThan the Pen
Helps you quickly and easilyimport, view, process, interpret,assign, and report your NMR data.
Don’t Settle for JUST NMR Processing!
NMR Software for Chemists:
ACD/1D NMR Assistant
5
Duane D. Miller to Receive 2008 Division of Medicinal Chemistry Award
Duane D. Miller, Harriett S. Van Vleet Professor of Medicinal Chemistry, and associate dean at the College of Pharmacy at the University of Tennessee at Memphis has been selected as the 2008 Division of Medicinal Chemistry award winner. Dr. Miller received a B.S. in Pharmacy from the University of Kansas, and a Ph.D. in medicinal chemistry at the University of Washington, where he was an NIH fellow. He began his career at The Ohio State University where he served as chair of the Department of Medicinal Chemistry and Pharmacognosy for 10 years, and was appointed as a Kimberly professor. In 1992, he moved to the University of Tennessee at Memphis as the Van Vleet Professor of Medicinal Chemistry, and in 2001 was appointed associate dean for research and graduate programs in the College of Pharmacy. The Division of Medicinal Chemistry Award is conferred biannually to a scientist or team of scientists with
a substantial record of contributions to the field of medicinal chemistry in research, mentorship and service to the discipline. Awardees cannot have previously received recognition from the American Chemical Society for their accomplishments. Professor Miller is being recognized for his many research contributions to medicinal chemistry in the stereochemistry of several different drug-receptor interactions, and more recently selective androgen receptor modulators (SARMs). As a part of a collaboration with Dr. Jim Dalton and GTx Inc., SARM compounds developed in his laboratory have advanced into clinical development for a variety of applications. His research program has been continuously funded by the National Institutes of Health since 1970. He has published over 250 papers, is listed as an inventor on at least 13 patents, and has presented over 80 invited lectures. Professor Miller has been recognized at both Ohio State and the University of Tennessee for his teaching skills at the graduate and undergraduate levels, and has mentored 23 Ph.D. students and 33 postdoctoral fellows. Dr. Miller’s service contributions include a variety of roles within the Division of Medicinal Chemistry, the American Association of Colleges of Pharmacy, and the American Association of Pharmaceutical Scientists. He has also been an active and consistent contributor to both universities in service roles. Professor Miller will receive the award at the 2008 National Medicinal Chemistry Symposium at the University of Pittsburgh June 15-19.
Kevin Duffy Selected to Receive 2008 David W. Robertson Memorial Award Kevin Duffy of GlaxoSmithKline Pharmaceuticals has been selected as the 2008 David W. Robertson Memorial Award winner. This award, conferred by the Division of Medicinal Chemistry of the American Chemical Society, and sponsored by the Pfizer Endowed Fund, recognizes scientists under the age of 40 who have made seminal contributions to the discovery of novel therapeutic agents, or who have made substantial contributions and discoveries in medicinal chemistry. Dr. Duffy is currently a group manager at GlaxoSmithKline, where he has spent his career after earning his Ph.D. in organic chemistry at the University of Edinburgh and postdoctoral studies at Harvard University. Dr. Duffy was recognized for key contributions that resulted in the discovery and development of eltrombopag (Promacta®), a novel, orally active small molecule thrombopoietin (TPO) mimetic whose NDA was recently filed for approval with the FDA for the treatment of chronic idiopathic thrombocytopenic purpura. In
clinical studies, eltrombopag has been shown to stimulate cells in the bone marrow to produce blood
6
platelets. There are currently no truly effective agents for this disorder. When this program was initiated, there were no small molecule mimics of the pharmacological actions of a protein. Kevin’s keen insight allowed he and his colleagues to replace undesirable features of a lead identified by high throughput screening with more drug-like fragments, and further optimized the properties of an advanced lead to improve potency and pharmacokinetic characteristics that ultimately resulted in eltrombopag. In addition, research Dr. Duffy has led and contributed to resulted in selection of seven development candidates in the past six years, including antiviral (HCV polymerase inhibitors), oncology (kinesin inhibitors), and supportive care indications. Many of these agents represent novel, first in class agents that if efficacious in humans, will be major advances in the treatment of these diseases. Kevin has maintained an active publications record and has reported on aspects of his research in peer-reviewed journals and at major, national symposia. Dr. Duffy will receive his award, which includes a $1000 honorarium and plaque, at the fall national meeting of the American Chemical Society at a symposium organized by the Division of Medicinal Chemistry.
Arun Ghosh to Receive the 2008 Robert M. Scarborough Award
Arun Ghosh, professor of chemistry and medicinal chemistry at Purdue University has been selected as the recipient of the 2008 Robert M. Scarborough Memorial Award. This award, endowed by Portola Pharmaceuticals, and conferred by the Division of Medicinal Chemistry of the American Chemical Society recognizes scientists under the age of 50 at the time of nomination. The awardee must have documented success in the discovery of pharmaceutical entities and/or a substantial body of significant research contributions in medicinal chemistry. Candidates should have a significant record of productivity as measured by the number and quality of scientific publications and issued patents. Nominees are expected to have demonstrated creativity and insight in medicinal chemistry and/or biology and employ pragmatic, empirical problem solving skills. Professor Ghosh earned his Ph.D. degree in organic chemistry at the University of Pittsburgh and completed postdoctoral studies at Harvard University. He began his academic career at the University of Illinois at Chicago, where he rose to the rank of professor. In
2005, he moved to his current position at Purdue University. Professor Ghosh is cited for his contributions to structure-based design of HIV protease inhibitors, where he introduced a natural product derivative as a key feature of darunavir (Prestiza®), a compound recently approved in 2006 for treatment of HIV infection resistant to first generation protease inhibitors. This modification contributed to the ability of the compound to treat HIV-1 that has developed resistance to other protease inhibitors. More recently, Dr. Ghosh has made seminal contributions to the structure-based design of CTS-21166, a compound in clinical development for the treatment of Alzheimer’s Disease that inhibits an enzyme responsible for the biosynthesis of a key molecule thought to be associated with the neurodegeneration seen in the disease. His research group was the first to accomplish the total synthesis of laulimalide, a structurally novel natural product that has shown potent anticancer activity. He continues to investigate the structure-based design of non-peptide and peptidomimetic ligands that interact with a variety of enzymes. In 12 years of independent research, Dr. Ghosh has authored over 150 papers, and is listed as a co inventor on 18 patents and patent applications. Dr. Ghosh will receive the award, which includes a $4000 honorarium and a plaque, at the Fall 2008 national meeting of the American Chemical Society at a symposium organized by the Division of Medicinal Chemistry.
Wouldn’t your discovery project benefitfrom good, new chemistry ideas?
AllChemTM from Tripos has them.AllChem enables you to generate and search an incredibly large number (~1020) of synthetically accessible and
medicinally relevant structures, while assessing costs and benefits during lead discovery and optimization.
AllChem ideas –
n Yield the desired biological profile n Provide structural novelty n Are “drug-like” in size
n Available on your desktop n Are easily synthesizable
Learn more about AllChem at Tripos booth #1510 at ACS in New Orleans. To schedule a demo or request more
information from Tripos’ scientists, e-mail [email protected].
There’s always been good chemistry between us www.tripos.com 1-800-572-1702
8
31st National Medicinal Chemistry Symposium to be held June 15-19, 2008
at the University of Pittsburgh The 31st National Medicinal Chemistry Symposium will be held at the University of Pittsburgh in Pittsburgh, PA from June 15-19, 2008. The local organizer is Prof. Barry Gold, and the program co-chairs are Mark Murcko and Peter Wipf. Registration is now open, and early registration rates of $550.00 will apply until April 30, 2008. The scientific program is complete, and can be viewed on the conference web site. For more information, or to register for the conference, visit the NMCS homepage at:
http://www.nmcs.pitt.edu
Division News in RSS Format ACSMEDI news and announcements are now posted periodically on the Division RSS feed. RSS (Really Simple Syndication) continually delivers the latest news directly to your reader (also known as a News Aggregator). RSS feeds have an URL just like a web page, except that they end in .rss or .xml. They are marked on most web pages with a red logo that either says XML or RSS. There are a variety of news readers that can be downloaded for free. Each time you start your news reader, the list for each of your subscriptions is updated automatically for continual access to the latest news. sports and technology. When you visit a web page, look for the red icon to get the RSS address. Members are encouraged to utilize this technology to receive Division news. This will help us minimize the number of emails sent out by the Division. For more information on using the Division RSS feed, go to:
http://www.acsmedchem.org
and follow the appropriate links.
Advertise in the ACSMEDI Newsletter
The ACSMEDI Newsletter is distributed twice a year to 10,500 medicinal and organic chemist members, and is freely accessible to all through the ACSMEDI homepage. In response to a number of inquiries, we have established the following advertising policy:
One-quarter page: $350.00 One-half page: $500.00 Full page: $900.00
To place an ad or obtain more information, contact the editor at [email protected].
2008 ACS Prospectives Series
Discovery and Selection of Successful Drug Candidates, May 4 – 7, 2008 at the San Francisco Mark Hopkins InterContinental
Mechanisms of Chemically-Induced Toxicity for Medicinal Chemistry, May 18 – 20, 2008 iat the Philadelphia Sheraton Society Hill
PK/PD for Medicinal Chemists, Sept 7 – 9, 2008 in Cambridge, MA at the Royal Sonesta Boston
Process Chemistry in the Pharmaceutical Industry, Sept 28 – 30, 2008 in Cambridge, MA at the Royal Sonesta Boston
Translational Biomarkers: Pathways to Phase II Survival, October 5 – 7, 2008 at The Philadelphia Crown Plaza Center City
Topics and Tactics in Current Drug Design, Oct 19 – 21, 2008 in Cambridge, MA at the Boston Marriott Cambridge
Organic Reactions and Syntheses, October 26 – 28, 2008 at The Philadelphia Hyatt Regency Penn's Landing For more information or to register, visit the ACS ProSpectives web site at:
http://www.acsprospectives.org
9
Second Annual Advances In Chemical Sciences Symposium
sponsored by NESACS, IUPAC and RSC-US Royal Sonesta Hotel, Cambridge, MA
April 11, 2008, 9:00 a.m.
This day long scientific conference will focus on Medicinal Chemistry, Organic Synthesis and Methodology. Eminent scientists from industry and academia will deliver plenary lectures. Confirmed Lecturers include:
Magid Abou-Gharbia, Wyeth
Eric J. Sorensen, Princeton University Timothy F. Jamison, Massachusetts Institute of Technology
Mathew Shair, Harvard University Mark Goulet, Merck Research Laboratory
John Piwinski, Schering Plough
The symposium will be followed by a networking reception and vendor exhibition
Symposium registration fee: $ 50.00 Attendance is Limited – Advanced Registration is REQUIRED
Please send your full contact information along with your check for $50 made payable to NESACS to
CHEM Administrative Secretary, NESACS
23 Cottage Street Natick, MA 01760
For additional details, please contact any of the Organizing Committee:
[email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected]
John Wiley and Sons Offers 20% Discount on All Books
Wiley and Sons now offers members of the Division of Medicinal Chemistry a 20% discount on all Wiley books across all content areas. Division members can order on wiley.com, and when checking out will obtain the discounted pricing. Orders can also be placed by phone at 1-800-callwiley. In order to receive the discount, have your membership number handy, and mention the discount code MCHEM.
11
The 8th Bristol Synthesis Meeting, Tuesday 15 April 2008 in the Victoria
Rooms, Bristol University. The 8th Bristol Synthesis Meeting will be held on Tuesday 15 April 2008 in the Victoria Rooms, Bristol University. The speakers are: Professor Stephen Martin, University of Texas at Austin - Recent Advances in the Synthesis of Heterocyclic Natural Products Professor Gerry Pattenden, University of Nottingham - Natural Product Synthesis and Biosynthesis Speculation Professor Herbert Waldmann, Max Planck Institute - Biology Oriented Synthesis (BIOS) Professor Tamio Hayashi, Kyoto University - Recent Advances in the Rhodium-Catalyzed Asymmetric Carbon-Carbon Bond Formation Professor K. Barry Sharpless, The Scripps Research Institute - Organic Reactivity: in, on, and under water. Coffees and teas, lunch and a wine reception will be provided. Registration fees are £5 for students and academics, £25 for others. For further information and on-line registration visit
http://www.chm.bris.ac.uk/synthesismeeting
or contact Professor V. K. Aggarwal at [email protected]. The deadline for registration is Wednesday, 26 March 2008.
12
Balticum Organicum SyntheticumJune 29 - July 2, 2008Vilnius, Lithuania
You are invited to Vilnius, Lithuania to participate in four days of organic chemistry, interaction and discussion between Baltic and Western scientists, and a unique cultural, linguistic and social experience. The programme is composed of two primary formats: plenary lectures by a distinguished roster of Baltic and international speakers, and poster sessions held in a congenial atmosphere to stimulate discussion. We aim for a balanced program of academic and industrial speakers presenting fundamental and practical aspects of organic synthesis. There will also be a full social programme of a reception, final banquet, city and university tours, and a concert. BOS will be limited to 300 scientists. The official language of the conference is English.
Conference Website: http://www.bos2008.eu
31st National Medicinal Chemistry Symposium University of Pittsburgh
Pittsburgh, Pennsylvania June 15-19, 2008
The 2008 National Medicinal Chemistry Symposia sponsored by the Division of Medicinal Chemistry of the American Chemical Society will be held in Pittsburgh, Pennsylvania on June 15-19, 2008.
General Chair: Dr. Barry Gold, University of Pittsburgh Program Co-chairs: Dr. Mark Murcko, Vertex Pharmaceuticals Dr. Peter Wipf, University of Pittsburgh
Session Topics Session Leaders________ Nucleic Acid Targeting Strategies Laurence Hurley, University of Arizona Molecular Approaches to Cancer Therapy Robert Abraham, Wyeth Research Hepatitis C Robert Schooley, UCSD Biomarkers/PET Donna Huryn, University of Pittsburgh Inflammation/immunology Robert Zamboni, Merck Frosst Research Virtual Library Design and Screening Patrick Walters, Vertex Pharmaceuticals Late-breaking session William Greenlee, Schering-Plough Medicinal Chemistry Award Session Donald Abraham, Virginia
Commonwealth University Find out more about the program, meeting venue and travel award information for pre- and post-doctoral students at our website: http://www.nmcs.pitt.edu.
13
Annual Reports in Medicinal Chemistry
Dear Fellow Medicinal Chemists,
Annual Reports in Medicinal Chemistry continues to be a key publication in our field for over forty years. Volume 42 has now been delivered, and preparation for Volume 43 (to be delivered at the end of 2008) is underway. The format for Volume 43 will stay essentially the same as previously recent volumes with sections based on therapeutic area focus, however, there will be an increased emphasis on Case Histories. I am writing you to solicit reviews appropriate for Annual Reports in Medicinal Chemistry. Listed below are the Section Editors for Volume 43. If you feel that you want to contribute a review for the book, please contact the appropriate Section Editor. All reviews are approximately ten pages in length, and Section Editors are responsible for the content of their sections. This solicitation to the general Medicinal Chemistry community is our attempt to make sure that we get the best reviews possible for Volume 43. Please consider contributing and contacting a Section Editor with a review theme. I would like to thank all involved with Volume 43 in advance, and am looking forward to making it a useful resource for the Medicinal Chemistry community. Please also note that I am actively soliciting feedback from the medicinal chemistry community as to how you might want Annual Reports in Medicinal Chemistry to change and evolve. Please feel free to e-mail me [[email protected]] with your thoughts and suggestions.
Sincerely, John Macor, PhD, Editor-in-Chief, Annual Reports in Medicinal Chemistry ([email protected])
Section Editors – Volume 43 - Annual Reports in Medicinal Chemistry
Central Nervous System Diseases - Albert J. Robichaud ([email protected]) Cardiovascular & Metabolic Diseases - Andy Stamford ([email protected]) Inflammatory, Pulmonary & Gastrointestinal Diseases - Joel Barrish ([email protected]) Oncology - David C. Myles ([email protected]) Infectious Diseases - John Primeau ([email protected]) Topics in Biology - John Lowe ([email protected]) Topics in Drug Design & Discovery - Manoj C. Desai ([email protected])
We are pleased to announce the twelfth meeting of the French American Chemistry Society (FACS XII), to be held June 8-12, 2008, in Santa Barbara, California. This conference will be held at the Fess Parker’s DoubleTree Resort, located directly across from the beach. For more information and registration forms, go to http://www.acsmedchem.org/facs12.pdf. Registration forms must be returned to the attention of Robert D Larsen, Ph.D., Amgen Inc., One Amgen Center Drive, 29-2-M-A, Thousand Oaks, CA 91320, BEFORE April 1, 2008 to ensure accommodations and receive the early registration rate. We have secured favorable rates at the DoubleTree. Please forward this flier to your colleagues. We are looking forward to seeing you and welcoming you to another outstanding conference.
14
The Division of Medicinal Chemistry Acknowledges Symposium Sponsors Division of Medicinal Chemistry symposia at National Meetings are presented in part through the financial support of sponsor companies. The Division is pleased to acknowledge the generous support of the following companies during 2007:
http://www.wyeth.com
http://www.teledyneisco.com
http://www.acdlabs.com/
http://www.merck.com/mrl/
http://www.nature.com/nrd/index.html
http://www.lilly.com
Sponsorship opportunities are available for all upcoming Division of Medicinal Chemistry Symposia. Symposium sponsors for national ACS meetings are acknowledged with a prominent sign outside the meeting room, and by session chairs during the symposium. In addition, a table is provided where company representatives can interact with meeting attendees, and provide promotional materials. For more information on symposium sponsorship, contact the Program Chair, Jim McCarthy ([email protected]) or the Division Chair, Don Abraham ([email protected]).
15
ACS Division of Medicinal Chemistry Complete Officers/LRPC List 2008
1. Regular Executive Committee Members
Chair 2008 Donald J. Abraham, Ph.D. Department of Medicinal Chemistry Virginia Commonwealth University 410 N. 12th Street Richmond, VA 23298-0581 (804) 828-8183 [email protected] Vice Chair 2008 Jeff Zablocki, Ph.D. CV Therapeutics, Inc. 3172 Porter Drive Palo Alto, CA 94304 (650) 384-8547 [email protected] Program Chair 2007-2008 James R. McCarthy, Ph.D. Lilly Corporate Center Indianapolis, IN 46285-0002 (317) 433-1345 [email protected]
Secretary and Public Relations 2008-2010 Patrick M. Woster, Ph.D. 3132 Applebaum Hall Wayne State University Detroit, MI 48202 (313) 577-1523 [email protected] Membership Chair Yanping Xu, Ph.D. Lilly Research Laboratories Lilly Corporate Center DC1910 Indianapolis, IN 46285 (317) 433-1113 [email protected]
Treasurer 2006-2008 Danny L. Lattin, Ph.D. 4950 Research Park Way Lawrence, KS 66047 (785) 843-3460 [email protected]
Academic Councilor 2008-2010 Richard A. Gibbs, Ph.D. Department of Medicinal Chemistry and Molecular Pharmacology 575 Stadium Mall Drive Purdue University West Lafayette, IN 47907-2091 (765) 494-1456 [email protected] Academic Councilor 2006-2008 Gunda I. Georg, Ph.D. Department of Medicinal Chemistry 308 Harvard St. S.E. 8-106 Weaver-Densford Hall College of Pharmacy University of Minnesota Minneapolis, MN 55455 (612) 624-9919 [email protected] Industrial Councilor 2007-2009 Ravi Nargund, Ph.D. Merck Research Laboratories RY 50G-301, P.O. Box 2000 Rahway, NJ 07065 (732) 594-3704 [email protected] Industrial Councilor 2006-2008 Peter R. Bernstein, Ph.D. Department of Chemistry AstraZeneca Pharmaceuticals 1800 Concord Pike Wilmington, DE 19803 (302) 886-8966 [email protected] Past Chair 2008 David P. Rotella, Ph.D. Wyeth Research CN 8000 Princeton NJ, 08543 (732) 274-4504 [email protected]
16
2. Alternate Councilors and Members-at-Large (Ad Hoc EC Members)
Academic Alternate Councilor 2006-2008 Kenneth A. Jacobson, Ph.D. NIH, 8 Center Drive MSC 0810, Building 8A, Room B1A-17 Bethesda, MD 20892, (301) 496-9024 [email protected]
Academic Alternate Councilor 2008-2010 Richard A. Glennon, Ph.D. Department of Medicinal Chemistry Virginia Commonwealth University 410 N. 12th Street Richmond, VA 23298-0581 (804) 828-8487 [email protected] Industrial Alternate Councilor 2007-2009 Jasbir Singh, Ph.D. Vice-President, Medicinal Chemistry deCODE Chemistry, Inc. 2501 Davey Road Woodridge, IL-60517 (630) 783-4915 [email protected] Industrial Alternate Councilor 2006-2008 Jill A. Panetta, Ph.D. Chief Scientific Officer, Innocentive Intech Park 11, Suite 300 6625 Network Way Indianapolis, IN 46278-1683 (317) 276-5793 [email protected]
Member-at-Large (Ad Hoc) 2008-2009 Andrew Stamford Schering Plough Research Institute K15-2545 2015 Galloping Hill Road Kenilworth NJ, 07033 (908) 740-3481 [email protected] Member-at-Large (Ad Hoc) 2008-2009 Yusuf Abul-Hajj Department of Medicinal Chemistry 308 Harvard St. S.E. 9-151 Weaver-Densford Hall College of Pharmacy University of Minnesota Minneapolis, MN 55455 (612) 624-5987 [email protected] Editor-in-Chief, Annual Reports in Medicinal Chemistry (2007-2011) John E. Macor, Ph.D. Executive Director, Neuroscience Discovery Chemistry Bristol-Myers Squibb 5 Research Parkway Wallingford, CT 06492 (203) 677-7092 [email protected] EFMC Liaison 2008 Thomas J. Perun, Ph.D. 47731 Old Houston Hwy Hempstead, TX 77445 [email protected]
17
3. Long Range Planning Committee Jeff Zablocki, Ph.D. (2008 Chair) CV Therapeutics, Inc. 3172 Porter Drive Palo Alto, CA 94304 (650) 384-8547 [email protected] Anandan Palani, Ph.D. (2008-2010) Schering Plough Research Institute 2015 Galloping Hill Road k15-1-1800 Kenilworth, NJ 07033 (908) 740-7158 [email protected] John E. Macor, Ph.D. (2006-2008) Executive Director, Neuroscience Discovery Chemistry Bristol-Myers Squibb 5 Research Parkway Wallingford, CT 06492 (203) 677-7092 [email protected] Milton L. Brown, Ph.D. (2006-2008) Lombardi Comprehensive Cancer Center Georgetown University Medical Center EP07 New Research Bldg. Box 571468 Washington, DC 20057 (202) 687-8603 [email protected] Michael S. VanNieuwenhze, Ph.D. (2006-2008) Department of Chemistry and Biochemistry University of California at San Diego 9500 Gilman Drive (MC 0358) La Jolla, CA 92093-0358 (858) 534-4183 [email protected] Michelle L. Lamb, Ph.D. (2008-2010) Principal Scientist AstraZeneca R&D Boston 35 Gatehouse Dr. Waltham, MA 02451 (781) 839-4401 [email protected]
Robert Fecik, Ph.D. (2007-2009) Assistant Professor Department of Medicinal Chemistry University of Minnesota 308 Harvard St. S.E., 8-101 WDH Minneapolis, MN 55454-0353 (612) 626-6523 [email protected] Robert J. DeVita, Ph.D. (2007-2009) Director, Medicinal Chemistry Merck Research Laboratories PO Box 2000, RY121E-22 Rahway, NJ 07065-0900 (732) 594-7039 [email protected] Gabriela Chiosis, Ph.D. (2007-2009) Program in Molecular Pharmacology&Chemistry Memorial Sloan-Kettering Cancer Center ZRB#2103 New York, NY10021 (646) 888-2235 [email protected] Hsiu-Chung (Ginnie) Yang, Ph.D. (2007-2009) Lilly Research Laboratories Lilly Corporate Center Eli Lilly and Company Indianapolis, IN 48285 (317) 433-2543 [email protected] Shelly McAlpine, Ph.D. (2007-2009) Dept. of Chemistry and Biochemistry Molecular Biology Institute 5500 Campanile Road, 208 CSL San Diego State University San Diego, CA 92182-1030 (619) 993-8609 [email protected] Tudor I. Oprea (2008-2010) Professor, Biochemistry and Molecular Biology University of New Mexico School of Medicine, Albuquerque, New Mexico 87131 (505) 272-8223 [email protected]
18
John Butera, Ph.D. (2007-2009) Wyeth Research CN 8000 Princeton, NJ 08510 (732) 274-4289 [email protected] Frank Wu, Ph.D. (2008-2010) Senior Principal Scientist Boehringer- Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road/PO Box 368 Ridgefield, CT 06877 (203) 791-6317 [email protected]
David G. Hangauer, Ph.D. (2008-2010) Associate Professor of Medicinal Chemistry & Chemistry Department of Chemistry & Senior Vice President for Research & Development & Co-Founder Kinex Pharmaceuticals, LLC 359 Natural Sciences Complex Box 603000 University at Buffalo The State University of New York Buffalo, NY 14260-3000 (716) 645-6299
We need your input!
Send your suggestions for symposia for MEDI national meeting scientific
programming to any member of the Executive Committee or Long Range Planning Committee. Proposals are reviewed by the Long Range Planning
Committee at each national ACS meeting, and symposia are selected one year in advance. The strength of Division programming comes directly through
suggestions from individual members.